Tech Company Financing Transactions
iTherx Pharmaceuticals Funding Round
Private investors participated in a $3.2 million capital raise for iTherx Pharmaceuticals. This venture round was announced on 11/7/2011.
Transaction Overview
Company Name
Announced On
11/7/2011
Transaction Type
Venture Equity
Amount
$3,173,595
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed. SEC regulatory filing.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
700 West E St. 801
San Diego, CA 92101
USA
San Diego, CA 92101
USA
Phone
Website
Email Address
Overview
iTherX is a clinical stage pharmaceutical company focused on the discovery and development of innovative treatments for Hepatitis C. This is a disease that affects almost 3% of the world's population, and is the major cause of chronic liver disease, cirrhosis, liver failure and primary liver cancer.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Jeffrey McKelvy
Chief Scientific Officer
Flossie Wong-Stahl
Browse more venture capital transactions:
Prev: 11/7/2011: iVerse Media venture capital transaction
Next: 11/7/2011: Airship venture capital transaction
Share this article
Where The Data Comes From
We do our best to record all VC transactions involving tech companies. All VC database entries reported here are derived from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs